miRNAs as potential game-changers in renal cell carcinoma: Future clinical and medicinal uses
Renal cell carcinoma (RCC) has the highest mortality rate of all genitourinary cancers, and
its prevalence has grown over time. While RCC can be surgically treated and recurrence is …
its prevalence has grown over time. While RCC can be surgically treated and recurrence is …
miRNAs as potential game-changers in renal cell carcinoma: Future clinical and medicinal uses.
MS Elballal, AM Sallam, AE Elesawy… - Pathology, Research …, 2023 - europepmc.org
Renal cell carcinoma (RCC) has the highest mortality rate of all genitourinary cancers, and
its prevalence has grown over time. While RCC can be surgically treated and recurrence is …
its prevalence has grown over time. While RCC can be surgically treated and recurrence is …
miRNAs as potential game-changers in renal cell carcinoma: Future clinical and medicinal uses
MS Elballal, AAM Sallam, AE Elesawy… - Pathology, research … - pubmed.ncbi.nlm.nih.gov
Renal cell carcinoma (RCC) has the highest mortality rate of all genitourinary cancers, and
its prevalence has grown over time. While RCC can be surgically treated and recurrence is …
its prevalence has grown over time. While RCC can be surgically treated and recurrence is …